Study to Evaluate the Efficacy, Safety, and Tolerability of Sarecycline for Treating Periorificial Dermatitis
Clinical trial NCT06461299 · COMPLETED
Trial details
- NCT number
- NCT06461299
- Sponsor
- The Dermatology Institute of Boston
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-17
- Primary completion
- 2024-03-31
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.